Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates

NCT00850122 is registered in ClinicalTrials.gov with Phillip Brian Smith as lead sponsor.

NCT NCT00850122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00850122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
Lead sponsor
Phillip Brian Smith
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2013
Completion date
July 31, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prematurity, sepsis